Hospital becomes the first in the world to use a 'sponge on a string' to detect oesophageal cancer
University College London Hospital switched to the pioneering Cytosponge to assess patients after NHS bosses banned the use of endoscopies during the pandemic. (Source: the Mail online | Health)
Source: the Mail online | Health - March 17, 2021 Category: Consumer Health News Source Type: news
A new type of recyclable: Finding new uses for established drugs
(Tokyo Medical and Dental University) Using cell culture and mouse model approaches, researchers from Tokyo Medical and Dental University (TMDU) have found a novel drug combination that can inhibit tumor growth in oral and esophageal carcinomas. They also identified a potential biomarker that can help predict patient sensitivity to this treatment. These findings provide valuable knowledge for the fight against these deadly cancers and demonstrate a potential new use for drugs currently approved for other diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 16, 2021 Category: Cancer & Oncology Source Type: news
Age Should Not Prevent Aggressive Esophageal Cancer Treatment Age Should Not Prevent Aggressive Esophageal Cancer Treatment
Neoadjuvant chemoradiation plus esophagectomy can be performed safely in well-selected older patients with locally advanced esophageal or esophagogastric junction cancer, according to a reviewMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 2, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
Those 70 years and older have similar postoperative complication scores and long - term survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 26, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Geriatrics, Journal, Source Type: news
Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially curative therapy, including neoadjuvant chemoradiotherapy and surgical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2021 Category: Pharmaceuticals Source Type: news
Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
Title: Chronic Heartburn Raises Odds for Cancers of Larynx, EsophagusCategory: Health NewsCreated: 2/22/2021 12:00:00 AMLast Editorial Review: 2/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 23, 2021 Category: Cancer & Oncology Source Type: news
Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 23, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, News, Source Type: news
Heartburn Raises Odds for Esophageal, Larynx Cancers
Researchers found that those with gastroesophageal reflux disease (GERD) had about twice the risk of developing cancers of the esophagus or larynx. (Source: WebMD Health)
Source: WebMD Health - February 22, 2021 Category: Consumer Health News Source Type: news
Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
MONDAY, Feb. 22, 2021 -- People with chronic heartburn may face increased risks of several rare types of cancer, a large U.S. government study shows.
Researchers found that among more than 490,000 Americans aged 50 and up, those with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 22, 2021 Category: General Medicine Source Type: news
Chronic heartburn doubles risk for certain cancers, study finds
People with chronic heartburn may be twice as likely to develop throat and esophageal cancers than those without the condition, according to a study published Monday by the journal Cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 22, 2021 Category: Consumer Health News Source Type: news
GERD Linked to Squamous Cell Cancers of Larynx, Esophagus
MONDAY, Feb. 22, 2021 -- Gastroesophageal reflux disease (GERD) appears to be associated with an increased risk for squamous cell cancers of the larynx and esophagus, according to a study published online Feb. 22 in Cancer.
Shao-Ming Wang, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2021 Category: Pharmaceuticals Source Type: news
Acid reflux disease may increase risk of cancers of the larynx and esophagus
(Wiley) Results from a large prospective study indicate that gastroesophageal reflux disease (GERD), which also causes heartburn symptoms, is linked with higher risks of various cancers of the larynx (or voice box) and esophagus. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 22, 2021 Category: Cancer & Oncology Source Type: news
Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks
(American College of Surgeons) Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2021 Category: Cancer & Oncology Source Type: news
Novel 3D printed stents deliver breakthrough treatment for oesophageal cancer
(University of South Australia) World-first 3D printed oesophageal stents developed by the University of South Australia could revolutionise the delivery of chemotherapy drugs to provide more accurate, effective and personalised treatment for patients with oesophageal cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2021 Category: International Medicine & Public Health Source Type: news
Higher Intensity Therapy and Surgical Risk in Esophageal Cancer Higher Intensity Therapy and Surgical Risk in Esophageal Cancer
Combining standard neoadjuvant chemotherapy for locally advanced esophageal cancer with either radiation or docetaxel did not increase the risk of surgical complications, investigators in the JCOG1109 trial reported.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
